Regulation of local availability of active tissue-type plasminogen activator in vivo in man

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 11, 2004, Pages 1960-1968

  Hrafnkelsdottir, Thordis ^a,b   Gudnason, T ^a,b   Wall, U ^a   Jern, C ^a,b   Jern, S ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Endothelium; Plasminogen activator inhibitor 1; Tissue plasminogen activator

Indexed keywords

DESMOPRESSIN; FIBROLASE; METHACHOLINE CHLORIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; CORRELATION FUNCTION; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; ENZYME REGULATION; FIBRINOLYSIS; FOREARM; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN SECRETION; VASCULAR ENDOTHELIUM;

ADULT; BRACHIAL ARTERY; CIRCADIAN RHYTHM; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HUMANS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

EID: 13244291340     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00948.x     Document Type: Article

References (31)

1. Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from the endothelium, by coagulation activation products. Ann N Y Acad Sci 1992; 667: 249-58.
2. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-24.
3. Rijken DC. Plasminogen activators and plasminogen activator inhibitors: biochemical aspects. Baillieres Clin Haematol 1995; 8: 291-312.
4. Nordenhem A, Wiman B. Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA/inhibitor complexes. Scand J Clin Laboratory Invest 1998; 58: 475-83.
5. Booth NA. Fibrinolysis and thrombosis. Baillieres Best Pract Res Clin Haematol 1999; 12: 423-33.
6. Chmielewska J, Ranby M, Wiman B. Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor: evidence for 'second-site' interactions. Biochem J 1988; 251: 327-32.
7. Jern C, Selin L, Jern S. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemost 1994; 72: 285-91.
8. Jern S, Selin L, Bergbrant A, Jern C. Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation in human forearm. Thromb Haemost 1994; 72: 588-94.
9. Jern C, Selin L, Jern S. Application of the perfused-forearm model to study release mechanisms of tissue-type plasminogen activator in man. Fibrinolysis 1994; 8 (Suppl. 2): 13-5.
10. Jern S, Wall U, Bergbrant A, Selin-Sjogren L, Jern C. Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension. Arterioscler Thromb Vasc Biol 1997; 17: 3376-83.
11. Jern C, Selin L, Tengborn L, Jern S. Sympathoadrenal activation and muscarinic receptor stimulation induce acute release of tissue-type plasminogen activator but not von Willebrand factor across the human forearm. Thromb Haemost 1997; 78: 887-91.
12. Wall U, Jern S, Tengborn L, Jern C. Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm. Blood 1998; 91: 529-37.
13. Newby DE, Wright RA, Ludlam CA, Fox KA, Boon NA, Webb DJ. An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium. Thromb Haemost 1997; 78: 1242-8.
14. Brown NJ, Gainer JV, Stein CM, Vaughan DE. Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension 1999; 33: 1431-5.
15. Minai K, Matsumoto T, Horie H, Ohira N, Takashima H, Yokohama H, Kinoshita M. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2001; 37: 1565-70.
16. Osterlund B, Andersson B, Haggmark S, Jern C, Johansson G, Seeman-Lodding H, Biber B. Myocardial ischemia induces coronary t-PA release in the pig. Acta Anaesthesiol Scand 2002; 46: 271-8.
17. Newby DE, McLeod AL, Uren NG, Flint L, Ludlam CA, Webb DJ, Fox KA, Boon NA. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking. direct link between endothelial dysfunction and atherothrombosis. Circulation 2001; 103: 1936-41.
18. Seeman-Lodding H, Haggmark S, Jern C, Jern S, Johansson G, Winso O, Biber B. Systemic levels and preportal organ release of tissue-type plasminogen activator are enhanced by PEEP in the pig. Acta Anaesthesiol Scand 1999; 43: 623-33.
19. Jern C, Seeman-Lodding H, Biber B, Winso O, Jern S. An experimental multiple-organ model for the study of regional net release/uptake rates of tissue-type plasminogen activator in the intact pig. Thromb Haemost 1997; 78: 1150-6.
20. Bjorkman JA, Jern S, Jern C. Cardiac sympathetic nerve stimulation triggers coronary t-PA release. Arterioscler Thromb Vasc Biol 2003; 23: 1091-7.
21. Wall U, Jern C, Jern S. High capacity for tissue-type plasminogen activator release from vascular endothelium in vivo. J Hypertens 1997; 15: 1641-7.
22. Ranby M, Nguyen G, Scarabin PY, Samama M. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay. Thromb Haemost 1989; 61: 409-14.
23. Meijer P, Pollet DE, Wauters J, Kluft C. Specificity of antigen assays of plasminogen activator inhibitor in plasma: Innotest PAI-1 immunoassay evaluated. Clin Chem 1994; 40: 110-5.
24. Chandler WL, Jascur ML, Henderson PJ. Measurement of different forms of tissue plasminogen activator in plasma. Clin Chem 2000; 46: 38-46.
25. Lucore CL, Sobel BE. Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications. Circulation 1988; 77: 660-9.
26. Chandler WL, Trimble SL, Loo SC, Mornin D. Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma. Blood 1990; 76: 930-7.
27. Kluft C, Jie AF, Rijken DC, Verheijen JH. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Thromb Haemost 1988; 59: 329-32.
28. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46: 860-7.
29. Simpson AJ, Booth NA, Moore NR, Bennett B. Distribution of plasminogen activator inhibitor (PAI-1) in tissues. J Clin Pathol 1991; 44: 139-43.
30. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EK. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 1993; 13: 1090-100.
31. Samad F, Loskutoff DJ. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med 1996; 2 568-82.